Ken Takahashi is aiming not just research for the research’s sake, but for research that leads to social return. In this spirit, Takahashi is actively acquiring patents from the results of his academic research.
In addition to the patents acquired, the research results published in numerous academic journals are highly regarded and have received various awards. In addition, Takahashi’s works have been reported in reputable media, such as EurekAlert!.
Press release: Heart attack modeled with human stem cells
Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived CardiomyocytesYun Liu*1, Yin Liang*1, Mengxue Wang*1, Chen Wang1, Heng Wei2, Keiji Naruse1, Ken Takahashi1
Preventive/therapeutic reagent for ischemic heart diseases. Takahashi K, Wang J, Naruse K. Patent number: 6073125 (Japan), Jan 13, 2017.
Cell culture platform. Nagai Y, Naruse K, Takahashi K, Tokuyama E. Patent number: 6074860 (Japan), Jan 20, 2017.
Method for producing cardiomyocytes. Takahashi K, Idei H, Naruse K. Patent application number: 2020-084982 (Japan), May 14, 2020.
Publications / Lectures
Visit ResearchMap , Orchid sites to see the complete list of Ken Takahashi’s publications, conference presentations, exhibitions, and more.
Award for Outstanding Research Achievement and Contribution. Asia Pacific Society for Biology and Medical Sciences. December, 2019.
Award for Outstanding Research Achievement. Asia Pacific Society for Biology and Medical Sciences. March, 2019.